Education
About Us
Working with TipRanks
Follow Us
NexgenRx Inc (TSE:NXG)
:NXG
Total Valuation
NexgenRx has a market cap or net worth of C$20.27M. The enterprise value is -C$2.48M.
Market CapC$20.27M
Enterprise Value-C$2.48M
Share Statistics
NexgenRx has 71,117,134 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding71,117,134
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NexgenRx’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count20
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of NexgenRx is ―. NexgenRx’s PEG ratio is ―.
PE Ratio―
PS Ratio1.15
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, NexgenRx had revenue of ― and earned -331.97K in profits. Earnings per share was ―.
Revenue―
Gross Profit10.82M
Operating Income-143.88K
Pretax Income―
Net Income-331.97K
EBITDA1.15M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
NexgenRx pays an annual dividend of C$0.004, resulting in a dividend yield of 3.51%
Dividend Per ShareC$0.004
Dividend Yield3.51%
Payout Ratio-800.00%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change36.36%
50-Day Moving Average0.27
200-Day Moving Average0.27
Relative Strength Index (RSI)53.02
Average Volume (3m)6.23K
Important Dates
NexgenRx upcoming earnings date is May 15, 2025, TBA Not Confirmed.
Last Earnings DateApr 3, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend DateApr 25, 2025
Financial Position
NexgenRx as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, NexgenRx has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
NexgenRx EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
NexgenRx has ― in cash and marketable securities with 1.75M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt1.75M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for NexgenRx is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―